Since January 2018, AbBcn, S.L. is participating in a H2020 project called “New Selenium-based Targeted Nanocapsules to treat Breast Cancer” (NEOSETAC) to develop a new treatment for breast cancer patients. On October 2nd, we attended to the fist workshop “Biomedical Applications of Nanotechnology” in Tulln, Austria, together with the other partners: ACIB, BOKU,ADSI, Karolinska Institutet, KAROLINSKA university Hospital, UAB and PRUAB.
We are now offering samples of p16 antibody clone IHC116. This high affinity antibody performs just as well as the E6H4 clone offered by Ventana - see attached comparison report.
Zika virus is largely known for causing brain abnormalities due to its ability to infect neural progenitor stem cells during early development. The journal Cancer Research has recently published a paper by Carolini Kaid et.al. exposing that this virus is also capable of infecting and destroying stem-like cancer cells from aggressive human embryonal tumors of the central nervous system, meaning that Zika could turn into a weapon against brain cancer. In their research, Carolini Kaid et.al. employed the GeneTex antibodies ZIKV NS2B (GTX133308) and anti-firefly Luciferase (GTX27358). Get updated reading their paper (DOI: 10.1158/0008-5472.CAN-17-3201) and check out the GeneTex offers in antibodies on http://www.genetex.com/